吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GILD 吉利德科学

盘后交易 11-18 16:21:14 EST

88.46

+0.06

+0.07%

盘后88.46

+0.000.00%

16:21 EST

最高89.04	最低87.63	成交量899.05万
今开88.39	昨收88.40	日振幅1.60%
总市值1,102亿	流通市值1,100亿	总股本12.46亿
成交额7.95亿	换手率0.72%	流通股本12.44亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GILD","market":"US","secType":"STK","nameCN":"吉利德科学","latestPrice":88.46,"timestamp":1731963600000,"preClose":88.4,"halted":0,"volume":8990512,"hourTrading":{"tag":"盘后","latestPrice":88.46,"preClose":88.46,"latestTime":"16:21 EST","volume":480733,"amount":42526948.773760006,"timestamp":1731964866868},"delay":0,"floatShares":1243798873,"shares":1246265857,"eps":0.097109,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.06,"latestTime":"11-18 16:21:14 EST","open":88.385,"high":89.04,"low":87.63,"amount":795306580.3053601,"amplitude":0.01595,"askPrice":88.85,"askSize":100,"bidPrice":88.46,"bidSize":436,"shortable":3,"etf":0,"ttmEps":0.097109,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1731978000000},"adr":0,"listingDate":696056400000,"adjPreClose":88.4,"adrRate":0,"dividendRate":0.034592,"preHourTrading":{"tag":"盘前","latestPrice":88.54,"preClose":88.4,"latestTime":"09:29 EST","volume":4351,"amount":384127.07778,"timestamp":1731940199999},"postHourTrading":{"tag":"盘后","latestPrice":88.46,"preClose":88.46,"latestTime":"16:21 EST","volume":480733,"amount":42526948.773760006,"timestamp":1731964866868},"volumeRatio":0.953705,"optionData":{"bulkOrders":[{"symbol":"GILD","call":true,"expireDate":1737090000000,"strike":"95.0","timestamp":1731944743155,"price":1.0700000524520874,"volume":5000,"amount":535000,"type":"+"},{"symbol":"GILD","call":true,"expireDate":1734670800000,"strike":"95.0","timestamp":1731944743144,"price":0.49000000953674316,"volume":5000,"amount":245000,"type":"-"}]},"impliedVol":0.26,"impliedVolPercentile":0.4622},"requestUrl":"/m/hq/s/GILD","defaultTab":"news","newsList":[{"id":"2483532664","title":"美股抗疫概念股多数下跌 Moderna跌超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483532664","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483532664?lang=zh_cn&edition=full","pubTime":"2024-11-16 07:07","pubTimestamp":1731712028,"startTime":"0","endTime":"0","summary":"每经AI快讯，当地时间11月15日，美股抗疫概念股多数下跌，Moderna跌超7%，吉利德科学跌约4%，诺瓦瓦克斯医药涨超1%，BioNTech跌超3%，阿斯利康跌逾2%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202411163241399145.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411163241399145.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1430594728.SGD","BK4139","LU1571399168.USD","BK4532","LU0889565916.HKD","BK4578","LU1839511570.USD","BK4585","BK4550","LU0109394709.USD","LU1585245621.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","LU0058720904.USD","BK4566","IE0002270589.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4568","BK4588","LU2087621335.USD","LU2468319806.SGD","NVAX","LU1066051498.USD","BK4547","GILD","LU0289739699.SGD","LU1066053197.SGD","BK4583","LU0234570918.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2483481309","title":"吉利德科学2024财年第三财季实现净利润12.53亿美元，同比减少42.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483481309","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483481309?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686424,"startTime":"0","endTime":"0","summary":"11月16日，吉利德科学公布财报，公告显示公司2024财年第三财季净利润为12.53亿美元，同比减少42.52%；其中营业收入为75.31亿美元，同比增加7.05%，每股基本收益为1.00美元。从资产负债表来看，吉利德科学总负债361.34亿美元，其中短期债务18.12亿美元，资产负债比为1.51，流动比率为1.27。机构评级：截至2024年11月16日，当前有26家机构对吉利德科学目标价做出预测，其中目标均价为95.50美元，其中最低目标价为69.00美元，最高目标价为125.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000126a23b8826&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000126a23b8826&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GILD"],"gpt_icon":0},{"id":"2483645309","title":"吉利德科学下跌3.03%，报89.32美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483645309","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483645309?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:55","pubTimestamp":1731686142,"startTime":"0","endTime":"0","summary":"11月15日，吉利德科学(GILD)盘中下跌3.03%，截至23:55，报89.32美元/股，成交2.52亿美元。财务数据显示，截至2024年09月30日，吉利德科学收入总额211.85亿美元，同比增长5.91%；归母净利润-13.03亿美元，同比减少130.76%。大事提醒：11月14日，吉利德科学获花旗首次给予评级Buy，目标价125美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/11/15235545362743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4566","LU1585245621.USD","LU0109394709.USD","BK4588","IE0002270589.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","BK4532","GILD","LU1571399168.USD","IE00BSNM7G36.USD","BK4585","BK4578","LU0889565916.HKD","BK4550","LU0234570918.USD","LU0289739699.SGD","LU0320765992.SGD","LU2087621335.USD","LU1839511570.USD","BK4568","IE00BKVL7J92.USD","LU1066051498.USD","LU1066053197.SGD","IE00B19Z3B42.SGD","LU1430594728.SGD","BK4139","LU2468319806.SGD","BK4583","LU0058720904.USD"],"gpt_icon":0},{"id":"2483807230","title":"吉利德科学下跌1.28%，报91.44美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483807230","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483807230?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:08","pubTimestamp":1731596924,"startTime":"0","endTime":"0","summary":"11月14日，吉利德科学(GILD)盘中下跌1.28%，截至23:08，报91.44美元/股，成交7503.39万美元。财务数据显示，截至2024年09月30日，吉利德科学收入总额211.85亿美元，同比增长5.91%；归母净利润-13.03亿美元，同比减少130.76%。大事提醒：11月12日，吉利德科学2024年三季度累计回购金额8亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/11/14230845314278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0289739699.SGD","BK4532","LU1430594728.SGD","GILD","IE00B19Z3B42.SGD","LU0889565916.HKD","IE00BZ1G4Q59.USD","BK4139","BK4585","LU2468319806.SGD","IE00BKVL7J92.USD","BK4578","BK4588","BK4583","LU0320765992.SGD","LU0234570918.USD","IE00BSNM7G36.USD","LU1066053197.SGD","BK4566","LU1066051498.USD","IE0002270589.USD","BK4550","BK4568","LU1571399168.USD","LU1585245621.USD","LU1839511570.USD","IE00B19Z3581.USD","LU0109394709.USD","LU2087621335.USD","LU0058720904.USD"],"gpt_icon":0},{"id":"2483898627","title":"吉利德(GILD.US)长效HIV疗法上市申请即将递交","url":"https://stock-news.laohu8.com/highlight/detail?id=2483898627","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483898627?lang=zh_cn&edition=full","pubTime":"2024-11-14 09:47","pubTimestamp":1731548842,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，吉利德科学今日公布其每半年注射一次的艾滋病毒衣壳抑制剂lenacapavir用于预防艾滋病毒感染的第二项关键3期试验PURPOSE 2的全部结果。分析显示，接受lenacapavir的受试者中，高达99.9%未感染艾滋病毒，且其预防艾滋病毒感染的效果，优于现有每日一次口服疗法。上个月，美国FDA授予lenacapavir用于艾滋病毒感染暴露前预防的突破性疗法认定。首款获批的艾滋病PrEP药物是由吉利德所开发的每日口服的Truvada，如果按指示服用，预防艾滋病的效果显著。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1210722.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BK4588","BK4550","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU1430594728.SGD","IE00B19Z3581.USD","LU2468319806.SGD","LU1571399168.USD","LU0234570918.USD","BK4585","LU0289739699.SGD","GILD","LU1585245621.USD","IE00BKVL7J92.USD","BK4578","LU0109394709.USD","BK4568","BK4532","BK4583","LU0889565916.HKD","IE00B19Z3B42.SGD","BK4566","IE0002270589.USD","LU0058720904.USD","IE00BSNM7G36.USD","LU1066051498.USD","LU2087621335.USD","LU1839511570.USD","LU1066053197.SGD"],"gpt_icon":0},{"id":"2483903794","title":"吉利德科学下跌1.21%，报95.86美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483903794","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483903794?lang=zh_cn&edition=full","pubTime":"2024-11-13 02:01","pubTimestamp":1731434493,"startTime":"0","endTime":"0","summary":"11月13日，吉利德科学(GILD)盘中下跌1.21%，截至02:01，报95.86美元/股，成交2.2亿美元。财务数据显示，截至2024年09月30日，吉利德科学收入总额211.85亿美元，同比增长5.91%；归母净利润-13.03亿美元，同比减少130.76%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/11/13020145223445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4583","IE00BZ1G4Q59.USD","BK4139","LU1066051498.USD","BK4532","IE00B19Z3B42.SGD","LU0889565916.HKD","LU1066053197.SGD","BK4566","GILD","IE00BSNM7G36.USD","IE00B19Z3581.USD","BK4550","IE0002270589.USD","LU1571399168.USD","IE00BKVL7J92.USD","LU0109394709.USD","LU2468319806.SGD","LU2087621335.USD","BK4585","LU0234570918.USD","LU0289739699.SGD","LU1430594728.SGD","LU1585245621.USD","BK4578","BK4588","LU0320765992.SGD","BK4568","LU1839511570.USD","LU0058720904.USD"],"gpt_icon":0},{"id":"2482494062","title":"吉利德：砍掉三条管线，CAR-T大卖35亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482494062","media":"生物药大时代","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482494062?lang=zh_cn&edition=full","pubTime":"2024-11-11 10:50","pubTimestamp":1731293459,"startTime":"0","endTime":"0","summary":"截至2024年9月30日，吉利德公司的现金、现金等价物和有价债务证券为50.37亿美元，而截至2023年12月31日为84亿美元。吉利德重新调整了全年业绩指引，将其产品总销售预期上调至278-281亿美元，高于此前的271-275亿美元。其中Yescarta 2024 Q3销售额3.87亿美元，同比下降1%，环比下降7%；CD19 CAR-T疗法Tecartus2024Q3销售额0.98亿美元，同比增长2%，环比下降8%。吉利德砍掉三条管线。吉利德公司表示将进一步调查这些数据，但拒绝回答有关死亡的问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111105229abb47233&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111105229abb47233&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2468319806.SGD","CAR","LU0058720904.USD","BK4568","BK4566","IE00B19Z3581.USD","BK4583","LU1066051498.USD","LU1839511570.USD","BK4022","IE0002270589.USD","IE00BSNM7G36.USD","LU0109394709.USD","LU0889565916.HKD","IE00BKVL7J92.USD","BK4578","BK4230","LU2087621335.USD","IE00BZ1G4Q59.USD","GILD","BK4139","BK4585","LU1066053197.SGD","LU1585245621.USD","LU1430594728.SGD","LU0320765992.SGD","BK4532","BK4550","LU0234570918.USD","LU1571399168.USD","LU0289739699.SGD","IE00B19Z3B42.SGD","BK4588"],"gpt_icon":1},{"id":"2481404861","title":"BMO上调吉利德科学目标价至102美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481404861","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481404861?lang=zh_cn&edition=full","pubTime":"2024-11-08 17:10","pubTimestamp":1731057014,"startTime":"0","endTime":"0","summary":"格隆汇11月8日｜BMO Capital：将吉利德科学的目标价从94美元上调至102美元，维持“跑赢大市”评级。(格隆汇)\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2024-11-08/doc-incvixhi1959631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["BMO","GILD"],"gpt_icon":0},{"id":"1113695151","title":"异动解读 | 吉利德科学业绩超预期 盘中股价大涨6.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113695151","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113695151?lang=zh_cn&edition=full","pubTime":"2024-11-08 11:07","pubTimestamp":1731035257,"startTime":"0","endTime":"0","summary":"2024年11月7日,生物医药公司吉利德科学股价盘中大涨6.76%,引发市场高度关注。\n\n此前,吉利德公布了2024年第三季度财报,营收同比增长7%至75.5亿美元,超出分析师预期。调整后每股收益2.02美元,亦高于市场平均预期水平。\n\n由于药品销售强劲增长,吉利德上调了2024年全年业绩指引,预计全年营收将在278亿至281亿美元区间,调整后每股收益区间则从原3.6至3.9美元提高至4.25至4.45美元,均超出了此前的指引区间和市场预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GILD"],"gpt_icon":0},{"id":"1196796754","title":"异动解读 | 吉利德科学盘中大涨 业绩超预期引发乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1196796754","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196796754?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:53","pubTimestamp":1730991201,"startTime":"0","endTime":"0","summary":"2024年11月7日,生物医药领域知名公司吉利德科学股价盘中大涨5.12%,引发市场普遍关注。此前,吉利德公布了2024年第三季度业绩,营收达到75.5亿美元,同比增长7%,超出市场预期。值得一提的是,由于药品销售增长强劲,吉利德科学上调了2024年全年业绩指引。多家券商就此上调了对吉利德的评级和目标股价,认为这款新药能极大提升吉利德科学在艾滋病预防领域的竞争力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GILD"],"gpt_icon":0},{"id":"2481861631","title":"吉利德科学盘中异动 早盘大幅上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481861631","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481861631?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:32","pubTimestamp":1730989963,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日22时32分，吉利德科学股票出现异动，股价大幅上涨5.10%。吉利德科学股票所在的制药行业中，整体涨幅为0.71%。消息层面，截至22时32分，《吉利德科学Q3业绩超预期并上调全年指引 指药品销售情况良好》资讯为影响吉利德科学的重要信息。集团称，每股盈利下降的部分原因是2020年收购Immunomedics而拨备17.5亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107223243a220ecf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107223243a220ecf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1066053197.SGD","LU0889565916.HKD","BK4550","IE00BKVL7J92.USD","LU1066051498.USD","LU1571399168.USD","BK4585","IE00B19Z3581.USD","BK4588","IE00B19Z3B42.SGD","LU0109394709.USD","LU2468319806.SGD","BK4578","BK4566","IE00BZ1G4Q59.USD","BK4139","BK4583","LU0320765992.SGD","BK4532","LU0058720904.USD","LU2087621335.USD","IE00BSNM7G36.USD","IE0002270589.USD","LU0234570918.USD","LU1585245621.USD","LU0289739699.SGD","GILD","BK4568","LU1839511570.USD","LU1430594728.SGD"],"gpt_icon":0},{"id":"2481083199","title":"吉利德科学(GILD)涨超1% Q3业绩超市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2481083199","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481083199?lang=zh_cn&edition=full","pubTime":"2024-11-07 19:55","pubTimestamp":1730980533,"startTime":"0","endTime":"0","summary":"金吾财讯 | 吉利德科学(GILD)涨超1%，截至发稿，报93.42美元。消息面上，公司公布第三季度业绩。期内，营收75.5亿美元，同比增长7%，市场预期为70亿美元；调整后每股收益2.02美元，低于去年同期的2.29美元，仍超出市场预期的1.55美元。鉴于药品销售情况良好，公司上调全年业绩指引，营收预测由271亿至275亿美元，上调为278亿至281亿美元，调整后每股收益预测由3.6至3.9美元，上调为4.25至4.45美元，市场预期分别为277.2亿美元和3.81美元。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/MTI5MjQwNzE0NzY0NzE5Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MTI5MjQwNzE0NzY0NzE5Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"281743","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","BK4139","LU1571399168.USD","BK4532","LU0889565916.HKD","BK4578","LU1839511570.USD","BK4585","BK4550","LU0109394709.USD","LU1585245621.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","LU0058720904.USD","BK4566","IE0002270589.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4568","BK4588","LU2087621335.USD","LU2468319806.SGD","LU1066051498.USD","GILD","LU0289739699.SGD","LU1066053197.SGD","BK4583","LU0234570918.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2481974176","title":"BUZZ-吉利德第三季度业绩超预期，预期上调后股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2481974176","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481974176?lang=zh_cn&edition=full","pubTime":"2024-11-07 19:21","pubTimestamp":1730978463,"startTime":"0","endTime":"0","summary":"11月7日 -  ** 制药商吉利德GILD.O股价盘前上涨1.8%至93.35美元 ** 由于销售额攀升了 7%，该公司的第三季度业绩超出了  华尔街的预期，从而导致该制药商上调了财年盈利预期。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nL4S3ME1B7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","BK4578","IE00B19Z3B42.SGD","LU1571399168.USD","BK4139","IE00BSNM7G36.USD","BK4568","IE00BKVL7J92.USD","LU1839511570.USD","BK4566","LU0058720904.USD","LU0289739699.SGD","LU1585245621.USD","BK4585","LU1430594728.SGD","LU1066053197.SGD","LU2087621335.USD","IE00BZ1G4Q59.USD","LU0889565916.HKD","BK4550","LU0234570918.USD","IE0002270589.USD","BK4583","LU1066051498.USD","LU0109394709.USD","BK4532","LU2468319806.SGD","IE00B19Z3581.USD","BK4588","LU0320765992.SGD"],"gpt_icon":0},{"id":"2481797502","title":"BUZZ-券商观点：投资者关注吉利德年底提交的艾滋病药物来那卡韦申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2481797502","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481797502?lang=zh_cn&edition=full","pubTime":"2024-11-07 18:37","pubTimestamp":1730975834,"startTime":"0","endTime":"0","summary":"BUZZ-券商观点：投资者关注吉利德年底提交的艾滋病药物来那卡韦申请11月7日 -  ** 吉利德科学公司GILD.O周三公布的第三季度财报大幅超出华尔街预期，销售额攀升了7%，这使得该制药商上调了对全年收益的展望。** 吉利德计划在今年年底前向美国监管机构申请批准来那卡韦。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nL4S3ME19W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","GILD","BK4207","BK4566","LU1839511570.USD","IE00BBT3K403.USD","BK4588","LU0289739699.SGD","LU0211326755.USD","LU1244550221.USD","IE00BYXW3230.USD","LU0310799852.SGD","LU1162221912.USD","LU2087621335.USD","BK4533","LU","LU0106831901.USD","LU0320765489.SGD","LU1032466523.USD","LU1585245621.USD","IE0034235303.USD","IE00BJTD4N35.SGD","IE0034235295.USD","IE0002270589.USD","LU0211327993.USD","IE0034235188.USD","BK4532","LU0320765992.SGD","BK4583","LU0058720904.USD","LU1430594728.SGD","LU0238689110.USD","IE00BJTD4V19.USD","IE00BFXG1179.USD","IE00BWXC8680.SGD","IE00B19Z3B42.SGD","LU0787776722.HKD","IE00B19Z3581.USD","LU0149725797.USD","LU0234572021.USD","BK4585","LU0683600562.USD","LU1066053197.SGD","IE00BLSP4452.SGD","LU0323591593.USD","IE00BKDWB100.SGD","LU0417517546.SGD","LU0203345920.USD","LU0109394709.USD","LU0971096721.USD"],"gpt_icon":0},{"id":"2481978961","title":"吉利德科学(GILD)Q3业绩超市场预期 上调全年业绩指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2481978961","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481978961?lang=zh_cn&edition=full","pubTime":"2024-11-07 17:43","pubTimestamp":1730972585,"startTime":"0","endTime":"0","summary":"金吾财讯 | 吉利德科学(GILD)公布第三季度业绩。期内，营收75.5亿美元，同比增长7%，市场预期为70亿美元；调整后每股收益2.02美元，低于去年同期的2.29美元，仍超出市场预期的1.55美元。集团称，每股盈利下降的部分原因是2020年收购Immunomedics而拨备17.5亿美元。鉴于药品销售情况良好，公司上调全年业绩指引，营收预测由271亿至275亿美元，上调为278亿至281亿美元，调整后每股收益预测由3.6至3.9美元，上调为4.25至4.45美元，市场预期分别为277.2亿美元和3.81美元。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/ZWIxN2UyMTAxNzg2ODk4NTUx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZWIxN2UyMTAxNzg2ODk4NTUx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"281732","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","IE0002270589.USD","LU0109394709.USD","BK4588","BK4550","LU1066051498.USD","GILD","LU1839511570.USD","BK4566","LU1585245621.USD","IE00BKVL7J92.USD","LU0234570918.USD","LU0320765992.SGD","BK4583","LU2087621335.USD","LU1066053197.SGD","BK4578","BK4568","IE00BZ1G4Q59.USD","BK4139","LU2468319806.SGD","LU0058720904.USD","LU0289739699.SGD","LU0889565916.HKD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","LU1571399168.USD","BK4585","BK4532"],"gpt_icon":0},{"id":"2481288922","title":"美股异动丨吉利德科学盘前涨超1.6%势创新高 Q3营收超预期并上调全年业绩指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2481288922","media":"港股那点事","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481288922?lang=zh_cn&edition=full","pubTime":"2024-11-07 17:14","pubTimestamp":1730970840,"startTime":"0","endTime":"0","summary":"格隆汇11月7日｜吉利德科学(GILD.US)美股盘前涨超1.6%，报93.17美元，开盘后股价势将创下历史新高。消息面上，吉利德科学第三季度营收75.5亿美元，同比增长7%，高于市场预期的70亿美元；调整后每股收益2.02美元，亦超出市场预期的1.55美元。鉴于药品销售情况良好，公司上调全年业绩指引，营收预测由271亿至275亿美元，上调为278亿至281亿美元，调整后每股收益预测由3.6至3.9美元，上调为4.25至4.45美元，市场预期分别为277.2亿美元和3.81美元。(格隆汇)\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/bxjj/2024-11-07/doc-incvfuhv2242433.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2024-11-07/doc-incvfuhv2242433.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GILD"],"gpt_icon":0},{"id":"1113008248","title":"盘前异动｜中国资产强势反弹；“特朗普交易”暂时熄火","url":"https://stock-news.laohu8.com/highlight/detail?id=1113008248","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113008248?lang=zh_cn&edition=full","pubTime":"2024-11-07 17:01","pubTimestamp":1730970108,"startTime":"0","endTime":"0","summary":"11月7日，美股三大股指期货小幅走高，截止发稿，道指期货涨0.19%，纳指期货涨0.19%，标普500指数期货涨0.18%。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","NIO","PDD","BEKE","NIO.SI","BK4548","LU0821914370.USD","XPEV","IE00BGV7N243.SGD","BK4583","LU0651947912.USD","AMC","DJT","JD","GILD","RIOT","EVS.SI","LU0516423174.USD","LU0287142896.SGD","AMC.AU"],"gpt_icon":1},{"id":"2481421839","title":"美国研究综述-BXP、Hubspot、高通公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2481421839","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481421839?lang=zh_cn&edition=full","pubTime":"2024-11-07 15:07","pubTimestamp":1730963275,"startTime":"0","endTime":"0","summary":"美国研究综述-BXP、Hubspot、高通公司路透11月7日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 BXP、Hubspot 和高通公司。* Clearwater Analytics Holdings Inc CWAN.N：摩根大通将其评级从中性上调至增持  * Hubspot Inc HUBS.N：摩根大通将目标价从560美元上调至635美元  * 高通QCOM.O：摩根大通将目标价从 195 美元上调至 200 美元 以下是路透周四报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nL4S3ME0W1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALB","CTNM","BK4528","LU1878469433.USD","MRK","IE00B4R5TH58.HKD","APP","CPNG","NOG","AIZ","DAWN","CLOV","CVS","EHTH","ANSS","FRSH","LNTH","GH","BMBL","IDYA","LU2125909593.SGD","BK4516","HCAT","CRL","LU1939255532.USD","GILD","KRUS","ARMK","HLNE","COR","GPOR","JKHY","KVYO","BK4223","BXP","CWAN","DV","ELF","IE00BJJMRZ35.SGD","AZPN","EMR","GHLD","BK4194","BROS","HUBS","LYFT","LU0965509101.SGD","IFF","LU1803068623.USD","CRC"],"gpt_icon":0},{"id":"2481175369","title":"吉利德科学全球副总裁金方千：继续加大对华投入，将中国创新药带向世界","url":"https://stock-news.laohu8.com/highlight/detail?id=2481175369","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481175369?lang=zh_cn&edition=full","pubTime":"2024-11-07 12:33","pubTimestamp":1730954033,"startTime":"0","endTime":"0","summary":"“我们已经是第三次参加进博会了，过去几年借助进博会的平台，我们既能够分享我们的研发成果及业务进展，同时也在加速我们的创新产品在中国上市，尽早惠及更多群体。最后，我们也通过进博会的平台开展了多方合作，与各类伙伴签约，从而加速我们在中国发展的进程。”第七届进博会期间，吉利德科学全球副总裁兼中国区总经理金方千在接受时代财经等媒体采访时表示。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411073232439486.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0058720904.USD","IE00BZ1G4Q59.USD","LU2087621335.USD","06978","BK4566","BK4578","LU1066053197.SGD","LU0234570918.USD","LU1066051498.USD","LU1430594728.SGD","BK4139","LU0889565916.HKD","IE00B19Z3B42.SGD","BK1574","LU0289739699.SGD","BK4550","BK4585","BK4532","BK4568","IE00BSNM7G36.USD","BK4583","LU1585245621.USD","IE0002270589.USD","LU1571399168.USD","GILD","LU1839511570.USD","BK1161","IE00BKVL7J92.USD","LU2468319806.SGD","LU0109394709.USD","IE00B19Z3581.USD","LU0320765992.SGD","BK4588"],"gpt_icon":0},{"id":"2481996089","title":"吉利德科学Q3业绩超预期并上调全年指引，药品销售情况良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2481996089","media":"格隆汇APP","labels":["viewpoints"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481996089?lang=zh_cn&edition=full","pubTime":"2024-11-07 09:12","pubTimestamp":1730941972,"startTime":"0","endTime":"0","summary":"调整后每股收益2.02美元。","market":"us","thumbnail":"https://static.tigerbbs.com/38ca14f80fba2163135e73cf419edff4","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/38ca14f80fba2163135e73cf419edff4"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107091306a21e4d68&s=b","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"吉利德科学Q3业绩超预期并上调全年指引，药品销售情况良好","news_tag":"viewpoints","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gilead.com","stockEarnings":[{"period":"1week","weight":-0.0846},{"period":"1month","weight":0.019},{"period":"3month","weight":0.1982},{"period":"6month","weight":0.3054},{"period":"1year","weight":0.1863},{"period":"ytd","weight":0.0912}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"吉利德科学公司于1987年6月22日在特拉华州成立，是一家以研究为基础的生物制药公司，致力于发现，开发和商业化未满足医疗需求的创新药物。该公司的主要重点领域包括病毒性疾病，炎性和纤维化疾病以及肿瘤学。","yearOnYearQuotes":[{"month":1,"riseRate":0.5625,"avgChangeRate":0.041198},{"month":2,"riseRate":0.393939,"avgChangeRate":0.002047},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.009403},{"month":4,"riseRate":0.545455,"avgChangeRate":0.013826},{"month":5,"riseRate":0.545455,"avgChangeRate":0.020012},{"month":6,"riseRate":0.636364,"avgChangeRate":0.026233},{"month":7,"riseRate":0.545455,"avgChangeRate":0.01619},{"month":8,"riseRate":0.545455,"avgChangeRate":0.033979},{"month":9,"riseRate":0.575758,"avgChangeRate":0.032629},{"month":10,"riseRate":0.515152,"avgChangeRate":0.000869},{"month":11,"riseRate":0.606061,"avgChangeRate":0.037983},{"month":12,"riseRate":0.40625,"avgChangeRate":0.011587}],"exchange":"NASDAQ","name":"吉利德科学","nameEN":"Gilead Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供吉利德科学(GILD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"吉利德科学,GILD,吉利德科学股票,吉利德科学股票老虎,吉利德科学股票老虎国际,吉利德科学行情,吉利德科学股票行情,吉利德科学股价,吉利德科学股市,吉利德科学股票价格,吉利德科学股票交易,吉利德科学股票购买,吉利德科学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供吉利德科学(GILD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}